| Biomarker ID | 1871 |
| PMID | 30373654 |
| Year | 2018 |
| Biomarker | Promoter methylation of: miR-193b+ miR-34b/c |
| Biomarker Basis | Methylation Based |
| Biomolecule | Methylation |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Methylated in Gleason Grade 2-5 |
| Odds Ratio/Hazard Ratio/Relative Risk | Multivariate: 3.843 (95% CI: 1.268-11.649) |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Specific Survival Vs No Survival |
| Type of Biomarker | Prognostic |
| Cohort | 15 normal prostate tissues along with 74 Prostate cancer samples were selected for analysis. 13 patients died due to PCa |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.017 |
| Method Used | KAPA SYBR FAST qPCR Kit |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |